» Articles » PMID: 18799981

Exercise Testing to Estimate Survival in Pulmonary Hypertension

Overview
Specialty Orthopedics
Date 2008 Sep 19
PMID 18799981
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Background: : The 6-min walk distance (6MWD) predicts survival in pulmonary hypertension (PH). The peak oxygen consumption (V O2peak) measured during a cardiopulmonary exercise test (CPET) also relates to survival in PH, and it is unknown how the prognostic information from measurements of ventilatory responses and gas exchange during CPET compares to the prognostic information obtained by the 6MWD alone. The aims of our study were to compare prognostic values of different exercise parameters in PH and to assess whether CPET adds prognostic value to the information from the 6MWD.

Methods: : After baseline right-heart catheterization and exercise testing, survival was assessed in a cohort of 115 PH patients.

Results: : During the 4 yr of follow-up, 18 patients died. At baseline, pulmonary arterial pressure was 49 +/- 17 mm Hg, the slope relating minute ventilation to carbon dioxide output (V E/V CO2slope) = 45 +/- 11, V O2peak = 15 +/- 6 mL.kg.min, increase in O2 pulse from rest to peak exercise (DeltaO2 pulse) = 5 +/- 2 mL.beat, and 6MWD = 445 +/- 128 m. For the prediction of mortality, the areas under the receiver operating curves were very similar for the different parameters and ranged from 0.69 to 0.74. Patients with a V E/V CO2slope < 48, V O2peak > 13.2 mL.kg.min, DeltaO2 pulse > 3.3 mL.beat, or a 6MWD > 399 m had a higher cumulative survival (P < 0.05). Multivariable Cox regression with a forward selection procedure showed that only DeltaO2 pulse improved the univariate 6MWD prediction model significantly (P < 0.05).

Conclusion: : CPET parameters predict survival in PH patients and add marginally to the prognostic value of the 6MWD.

Citing Articles

Physical exercise for pulmonary arterial hypertension diagnosis and therapy.

Lwin M, Masding A, McCabe C Int J Cardiol Congenit Heart Dis. 2025; 19:100565.

PMID: 40066343 PMC: 11891737. DOI: 10.1016/j.ijcchd.2025.100565.


Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.

Tarras E, Singh I, Kreiger J, Joseph P J Clin Med. 2025; 14(3).

PMID: 39941482 PMC: 11818252. DOI: 10.3390/jcm14030804.


Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease.

Alotaibi M, Yang J, Papamatheakis D, McGuire W, Fernandes T, Morris T Respir Res. 2024; 25(1):121.

PMID: 38468264 PMC: 10926602. DOI: 10.1186/s12931-024-02746-w.


The Current Role of Cardiopulmonary Exercise Test in the Diagnosis and Management of Pulmonary Hypertension.

Pezzuto B, Agostoni P J Clin Med. 2023; 12(17).

PMID: 37685532 PMC: 10487723. DOI: 10.3390/jcm12175465.


Lack of concordance between the different exercise test measures used in the risk stratification of patients with pulmonary arterial hypertension.

Mora Cuesta V, Martinez Menaca A, Iturbe Fernandez D, Tello Mena S, Alonso Lecue P, Fernandez Marquez D Pulm Circ. 2022; 12(4):e12149.

PMID: 36325509 PMC: 9618288. DOI: 10.1002/pul2.12149.